Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
Misung Park, Do‐Hee Kim, Sunghyub Ko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6806-6806
Open Access | Times Cited: 212
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 153
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 97
Curcumin: An epigenetic regulator and its application in cancer
Tianqi Ming, Tao Qiu, Shun Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113956-113956
Closed Access | Times Cited: 72
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
HDAC-targeting epigenetic modulators for cancer immunotherapy
Binbin Cheng, Wei Pan, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116129-116129
Closed Access | Times Cited: 32
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 21
The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications
Daoqi Zhu, Siying Zeng, Chao Su, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy
Junhua Li, Quan Zhao, Nan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 13226-13240
Closed Access | Times Cited: 17
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
Dying to survive: harnessing inflammatory cell death for better immunotherapy
Long Cheng, Yibo Wang, Ying Zhang
Trends in cancer (2025)
Closed Access | Times Cited: 2
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment
Yi-Chen Sun, Jing Han Hong, Zhiqiang Ning, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response
Amarilis Pérez-Baños, María Alejandra Gleisner, Iván Flores, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 4, pp. 572-585
Closed Access | Times Cited: 31
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment
Yuanyuan Pan, Wenjing Yang, Bo Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 26
Self-assembled albumin nanoparticles induce pyroptosis for photodynamic/photothermal/immuno synergistic therapies in triple-negative breast cancer
Jianquan Yang, Wen Guo, Rong Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Activation of the cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium(iii) metallointercalator
Yue Zheng, Xiaoxiao Chen, Dongyang Zhang, et al.
Chemical Science (2023) Vol. 14, Iss. 25, pp. 6890-6903
Open Access | Times Cited: 23
STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment
Feng Ao, Xi Li, Yan Zhi Tan, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 296-308
Closed Access | Times Cited: 13
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 12
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top